1 reports of this reaction
3.2% of all SALICYLIC ACID 17% WART REMOVER reports
#6 most reported adverse reaction
CONDITION AGGRAVATED is the #6 most commonly reported adverse reaction for SALICYLIC ACID 17% WART REMOVER, manufactured by AAA Pharmaceutical, Inc.. There are 1 FDA adverse event reports linking SALICYLIC ACID 17% WART REMOVER to CONDITION AGGRAVATED. This represents approximately 3.2% of all 31 adverse event reports for this drug.
Patients taking SALICYLIC ACID 17% WART REMOVER who experience condition aggravated should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
CONDITION AGGRAVATED is moderately reported among SALICYLIC ACID 17% WART REMOVER users, representing a notable but not dominant share of adverse events.
In addition to condition aggravated, the following adverse reactions have been reported for SALICYLIC ACID 17% WART REMOVER:
The following drugs have also been linked to condition aggravated in FDA adverse event reports:
CONDITION AGGRAVATED has been reported as an adverse event in 1 FDA reports for SALICYLIC ACID 17% WART REMOVER. This does not prove causation, but indicates an association observed in post-market surveillance data.
CONDITION AGGRAVATED accounts for approximately 3.2% of all adverse event reports for SALICYLIC ACID 17% WART REMOVER, making it a notable side effect.
If you experience condition aggravated while taking SALICYLIC ACID 17% WART REMOVER, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.